76 related articles for article (PubMed ID: 1666564)
1. The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex.
Godbout R; Mantz J; Glowinski J; Thierry AM
Eur J Pharmacol; 1991 Oct; 204(1):97-100. PubMed ID: 1666564
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
[TBL] [Abstract][Full Text] [Related]
3. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei.
Mantz J; Godbout R; Tassin JP; Glowinski J; Thierry AM
Brain Res; 1990 Jul; 524(1):22-30. PubMed ID: 2119244
[TBL] [Abstract][Full Text] [Related]
5. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.
Stutzmann JM; Eon B; Lucas M; Blanchard JC; Laduron PM
Sleep; 1992 Apr; 15(2):119-24. PubMed ID: 1579785
[TBL] [Abstract][Full Text] [Related]
6. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
Lejeune F; Millan MJ
Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
[TBL] [Abstract][Full Text] [Related]
7. [Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)].
Jaton AL; Vigouret JM; Dravid A
J Physiol (Paris); 1981; 77(2-3):405-11. PubMed ID: 7288655
[TBL] [Abstract][Full Text] [Related]
8. Clozapine--a serotonin antagonist?
Fink H; Morgenstern R; Oelssner W
Pharmacol Biochem Behav; 1984 Apr; 20(4):513-7. PubMed ID: 6728869
[TBL] [Abstract][Full Text] [Related]
9. Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?
Stutzmann JM; Eon B; Darche F; Lucas M; Rataud J; Piot O; Blanchard JC; Laduron PM
Neurosci Lett; 1991 Jul; 128(1):4-8. PubMed ID: 1681477
[TBL] [Abstract][Full Text] [Related]
10. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
11. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
Gronier B
Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
[TBL] [Abstract][Full Text] [Related]
12. Integrity of the mesocortical dopaminergic system is necessary for complete expression of in vivo hippocampal-prefrontal cortex long-term potentiation.
Gurden H; Tassin JP; Jay TM
Neuroscience; 1999; 94(4):1019-27. PubMed ID: 10625044
[TBL] [Abstract][Full Text] [Related]
13. Responses of serotonergic and non-serotonergic neurons in the rat nucleus raphe magnus to systemic lysergic acid diethylamide.
Wei JB; Chiang CY
Neurosci Res; 1986 Feb; 3(3):268-73. PubMed ID: 3703384
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
15. Pressor effects of electrical stimulation of the dorsal and median raphe nuclei in anesthetized rats.
Kuhn DM; Wolf WA; Lovenberg W
J Pharmacol Exp Ther; 1980 Aug; 214(2):403-9. PubMed ID: 6104727
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile.
Malgouris C; Flamand F; Doble A
Eur J Pharmacol; 1993 Mar; 233(1):29-35. PubMed ID: 8386088
[TBL] [Abstract][Full Text] [Related]
17. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
[TBL] [Abstract][Full Text] [Related]
18. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.
Sprouse JS; Aghajanian GK
Synapse; 1987; 1(1):3-9. PubMed ID: 3505364
[TBL] [Abstract][Full Text] [Related]
20. [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.
Fajolles C; Boireau A; Ponchant M; Laduron PM
Eur J Pharmacol; 1992 May; 216(1):53-7. PubMed ID: 1526254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
